PODD

266.57

3.90% 10.01

Handel nachbörslich: 266.57

Insulet Corporation (PODD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt PODD? Forum Prognose

Schlusskurs vom Vortag:

$256.56

Offen:

$256.56

24-Stunden-Volumen:

1.18M

Relative Volume:

2.15

Marktkapitalisierung:

$18.70B

Einnahmen:

$1.98B

Nettoeinkommen (Verlust:

$420.90M

KGV:

155.89

EPS:

1.71

Netto-Cashflow:

$218.20M

1W Leistung:

-1.03%

1M Leistung:

-0.00%

6M Leistung:

+33.75%

1J Leistung:

+28.18%

1-Tages-Spanne:

$256.56

$270.70

1-Wochen-Bereich:

$254.79

$271.18

52-Wochen-Spanne:

$160.19

$279.77

Insulet Corporation Stock (PODD) Company Profile

Firmenname

Insulet Corporation

Sektor

Healthcare (1176)

Branche

Medical Devices (148)

Telefon

978-600-7000

Adresse

100 NAGOG PARK, ACTON, MA

Mitarbeiter

3,000

Twitter

@insulet_uk

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

PODD's Discussions on Twitter

Vergleichen Sie PODD mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PODD Insulet Corporation	266.57	18.70B	1.98B	420.90M	218.20M	5.84
ABT Abbott Laboratories	114.23	198.13B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	364.60	138.99B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	88.95	131.10B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	81.03	103.90B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	74.81	44.12B	6.60B	4.16B	490.10M	6.93

Insulet Corporation Stock (PODD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-11-06	Eingeleitet	Bernstein	Outperform
2024-05-30	Eingeleitet	Redburn Atlantic	Buy
2024-05-07	Hochstufung	Wolfe Research	Peer Perform → Outperform
2023-12-21	Hochstufung	Robert W. Baird	Neutral → Outperform
2023-12-04	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2023-10-02	Hochstufung	Jefferies	Hold → Buy
2023-08-21	Hochstufung	Citigroup	Neutral → Buy
2023-08-21	Herabstufung	Robert W. Baird	Outperform → Neutral
2023-05-30	Fortgesetzt	Morgan Stanley	Equal-Weight
2023-01-26	Eingeleitet	Wolfe Research	Peer Perform
2022-11-04	Hochstufung	Piper Sandler	Neutral → Overweight
2022-10-18	Eingeleitet	Barclays	Equal Weight
2022-10-12	Eingeleitet	Jefferies	Hold
2022-07-11	Herabstufung	Citigroup	Buy → Neutral
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-03	Hochstufung	BTIG Research	Neutral → Buy
2022-02-02	Hochstufung	UBS	Neutral → Buy
2022-01-31	Hochstufung	Oppenheimer	Perform → Outperform
2021-07-21	Fortgesetzt	Cowen	Outperform
2021-05-25	Eingeleitet	Barclays	Overweight
2021-04-01	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2021-03-19	Hochstufung	Canaccord Genuity	Hold → Buy
2021-01-29	Herabstufung	Piper Sandler	Overweight → Neutral
2020-12-16	Herabstufung	Citigroup	Buy → Neutral
2020-07-28	Eingeleitet	Wells Fargo	Overweight
2020-04-24	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-04-03	Eingeleitet	BofA/Merrill	Neutral
2020-03-31	Herabstufung	Berenberg	Buy → Hold
2020-03-05	Eingeleitet	Citigroup	Buy
2019-12-10	Eingeleitet	CFRA	Sell
2019-10-23	Eingeleitet	Stifel	Hold
2019-10-18	Herabstufung	Canaccord Genuity	Buy → Hold
2019-10-14	Herabstufung	BTIG Research	Buy → Neutral
2019-10-04	Herabstufung	UBS	Buy → Neutral
2019-10-03	Herabstufung	Guggenheim	Buy → Neutral
2019-08-06	Hochstufung	JP Morgan	Neutral → Overweight
2019-06-10	Herabstufung	Northland Capital	Outperform → Market Perform
2019-05-06	Hochstufung	BTIG Research	Neutral → Buy
2018-04-20	Eingeleitet	Berenberg	Buy
2018-02-22	Bestätigt	Barclays	Overweight
2018-01-08	Hochstufung	Raymond James	Mkt Perform → Outperform
2017-11-03	Hochstufung	Canaccord Genuity	Hold → Buy
2017-09-15	Eingeleitet	Barclays	Overweight

Alle ansehen

Insulet Corporation Aktie (PODD) Neueste Nachrichten

Dec 20, 2024

Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Dec 19, 2024

Dec 18, 2024

Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly - Simply Wall St

Dec 18, 2024

Dec 17, 2024

Insulet corp EVP Benjamin Eric sells $1.17 million in shares By Investing.com - Investing.com Australia

Dec 17, 2024

Insulet corp EVP Benjamin Eric sells $1.17 million in shares - Investing.com India

Dec 17, 2024

Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga

Dec 17, 2024

Stocks Fall As Breadth Remains Weak; Fortinet, Insulet, Embraer In FocusVideoIBD - Investor's Business Daily

Dec 17, 2024

Dec 15, 2024

Virtu Financial LLC Makes New $616,000 Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 15, 2024

Toronto Dominion Bank Buys 3,117 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 15, 2024

Dec 14, 2024

Insulet Co. (NASDAQ:PODD) Stake Raised by Geode Capital Management LLC - MarketBeat

Dec 14, 2024

Dec 13, 2024

Insulet's SWOT analysis: tubeless pump maker's stock faces competition - Investing.com

Dec 13, 2024

Why Insulet (PODD) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Dec 13, 2024

Insulet Co. (NASDAQ:PODD) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat

Dec 13, 2024

Orion Portfolio Solutions LLC Purchases 3,623 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 13, 2024

Dec 12, 2024

Insulet stock soars to 52-week high, reaching $279.42 - Investing.com India

Dec 12, 2024

RMD or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance

Dec 12, 2024

Insulet stock soars to 52-week high, reaching $279.42 By Investing.com - Investing.com UK

Dec 12, 2024

National Bank of Canada FI Decreases Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 12, 2024

Dec 11, 2024

Insulet corp executive sells $252,192 in common stock By Investing.com - Investing.com Nigeria

Dec 11, 2024

Insulet corp executive sells $252,192 in common stock - Investing.com India

Dec 11, 2024

Should You Continue to Retain Insulet Stock in Your Portfolio Now? - MSN

Dec 11, 2024

Tandem Diabetes (TNDM) and Insulet (PODD) Volatility Attributed to Channel-Check Firm - StreetInsider.com

Dec 11, 2024

Dec 10, 2024

Google Takes Quantum Leap But Growth Weak Again; AppLovin, Insulet In Focus TooVideoIBD - Investor's Business Daily

Dec 10, 2024

Quantinno Capital Management LP Acquires 7,270 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 10, 2024

Insulet Co. (NASDAQ:PODD) Shares Bought by Nomura Asset Management Co. Ltd. - MarketBeat

Dec 10, 2024

Dec 09, 2024

3,459 Shares in Insulet Co. (NASDAQ:PODD) Purchased by SGL Investment Advisors Inc. - MarketBeat

Dec 09, 2024

Insulet Co. (NASDAQ:PODD) Position Trimmed by Groupama Asset Managment - MarketBeat

Dec 09, 2024

XTX Topco Ltd Acquires Shares of 6,351 Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 09, 2024

Dec 07, 2024

Insulet successfully defends its Intellectual property against EOFlow - Medical Buyer

Dec 07, 2024

Dec 06, 2024

Insulet wins $452M in lawsuit against rivals over medical device trade secrets - Cardiovascular Business

Dec 06, 2024

Dec 05, 2024

Jury awards Insulet $452M against Eoflow in trade secrets case - BioWorld Online

Dec 05, 2024

Insulet wins $452M in trade secret case By Investing.com - Investing.com Australia

Dec 05, 2024

Insulet Wins $452M Trade Secrets Verdict Against EOFlow - USA Herald

Dec 05, 2024

Readystate Asset Management LP Trims Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat

Dec 05, 2024

Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters

Dec 05, 2024

Insulet Wins $452M Jury Verdict in Trade Secrets Battle with EOFlow - USA Herald

Dec 05, 2024

Insulet awarded $452M in EOFlow patent fight - MedTech Dive

Dec 05, 2024

Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial - Bloomberg Law

Dec 05, 2024

Insulet's Legal Win Against EOFlow Over Trade Secret Theft - Finimize

Dec 05, 2024

BREAKING: Insulet Corp. Wins $452M In Trade Secret Theft Trial - Law360

Dec 05, 2024

Insulet Wins $452 Million Trade Secret Victory Against EOFlow - MPO-mag

Dec 05, 2024